Bookmark

Add to MyYahoo RSS

Guidant News

News on Guidant (Ticker: BSX) continually updated from thousands of sources around the net.

21 hrs ago | Business Wire

Fitch Affirms Boston Scientific's IDR at 'BBB-'; Outlook Stable

A full list of BSX's ratings follows at the end of this release. The rating action applies to approximately $4.25 billion of debt.

Comment?

Related Topix: Startups, Boston Scientific, Medical Equipment, Medicine, Healthcare Industry

Mon Jul 07, 2014

AmericanBankingNews.com

Boston Scientific Coverage Initiated by Analysts at CRT Capital

The firm set a "buy" rating and a $16.00 price target on the stock. CRT Capital's price objective indicates a potential upside of 22.89% from the company's current price.

Comment?

Related Topix: Medicine, Boston Scientific, Medical Equipment, Healthcare Industry, Advanced Bionics, Startups, SSI Technologies, Balloon

•••
•••
•••
•••
•••

Seattle Jobs

•••
•••
•••
•••